期刊
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
卷 1865, 期 11, 页码 1664-1675出版社
ELSEVIER
DOI: 10.1016/j.bbapap.2017.05.009
关键词
Review; Covalent modifiers; Irreversible inhibition; Computer modeling; Docking; QM/MM; Bioinformatics; pK(a); Cysteine; Michael addition; Kinase
资金
- NSERC of Canada [418505-2012]
- School of Graduate Studies at Memorial University
- ACENET
In this review, we present a summary of how computer modeling has been used in the development of covalent modifier drugs. Covalent-modifier drugs bind by forming a chemical bond with their target. This covalent binding can improve the selectivity of the drug for a target with complementary reactivity and result in increased binding affinities due to the strength of the covalent bond formed. In some cases, this results in irreversible inhibition of the target, but some targeted covalent inhibitor (TCI) drugs bind covalently but reversibly. Computer modeling is widely used in drug discovery, but different computational methods must be used to model covalent modifiers because of the chemical bonds formed. Structural and bioinformatic analysis has identified sites of modification that could yield selectivity for a chosen target. Docking methods, which are used to rank binding poses of large sets of inhibitors, have been augmented to support the formation of protein ligand bonds and are now capable of predicting the binding pose of covalent modifiers accurately. The pK(a)'s of amino acids can be calculated in order to assess their reactivity towards electrophiles. QM/MM methods have been used to model the reaction mechanisms of covalent modification. The continued development of these tools will allow computation to aid in the development of new covalent-modifier drugs. This article is part of a Special Issue entitled: Biophysics in Canada, edited by Lewis Kay, John Baenziger, Albert Berghuis and Peter Tieleman.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据